Becton Dickinson Price to Sales Ratio 2010-2023 | BDX
Historical PS ratio values for Becton Dickinson (BDX) over the last 10 years. The current P/S ratio for Becton Dickinson as of April 24, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Becton Dickinson P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2024-04-24 |
233.83 |
|
3.46 |
| 2023-12-31 |
242.86 |
$67.61 |
3.59 |
| 2023-09-30 |
256.46 |
$67.53 |
3.80 |
| 2023-06-30 |
261.00 |
$66.46 |
3.93 |
| 2023-03-31 |
243.83 |
$65.67 |
3.71 |
| 2022-12-31 |
249.51 |
$65.33 |
3.82 |
| 2022-09-30 |
217.84 |
$63.98 |
3.40 |
| 2022-06-30 |
240.20 |
$63.20 |
3.80 |
| 2022-03-31 |
251.90 |
$63.76 |
3.95 |
| 2021-09-30 |
231.21 |
$65.36 |
3.54 |
| 2021-06-30 |
228.01 |
$63.88 |
3.57 |
| 2021-03-31 |
227.19 |
$64.55 |
3.52 |
| 2020-12-31 |
233.00 |
$61.35 |
3.80 |
| 2020-09-30 |
215.92 |
$58.68 |
3.68 |
| 2021-12-31 |
237.37 |
$60.80 |
3.90 |
| 2020-06-30 |
221.29 |
$61.04 |
3.63 |
| 2020-03-31 |
211.82 |
$63.37 |
3.34 |
| 2019-12-31 |
249.87 |
$63.45 |
3.94 |
| 2019-09-30 |
231.70 |
$63.25 |
3.66 |
| 2019-06-30 |
230.15 |
$63.21 |
3.64 |
| 2019-03-31 |
227.33 |
$62.97 |
3.61 |
| 2018-12-31 |
204.47 |
$63.22 |
3.23 |
| 2018-09-30 |
236.07 |
$61.44 |
3.84 |
| 2018-06-30 |
216.05 |
$58.96 |
3.66 |
| 2018-03-31 |
194.80 |
$57.09 |
3.41 |
| 2017-12-31 |
191.78 |
$54.93 |
3.49 |
| 2017-09-30 |
174.95 |
$54.96 |
3.18 |
| 2017-06-30 |
173.57 |
$55.65 |
3.12 |
| 2017-03-31 |
162.57 |
$56.62 |
2.87 |
| 2016-12-31 |
146.13 |
$57.15 |
2.56 |
| 2016-09-30 |
157.95 |
$57.54 |
2.75 |
| 2016-06-30 |
148.49 |
$57.43 |
2.59 |
| 2016-03-31 |
132.41 |
$57.23 |
2.31 |
| 2015-12-31 |
133.79 |
$53.33 |
2.51 |
| 2015-09-30 |
114.69 |
$50.66 |
2.26 |
| 2015-06-30 |
121.92 |
$46.86 |
2.60 |
| 2015-03-31 |
123.06 |
$42.84 |
2.87 |
| 2014-09-30 |
96.72 |
$42.75 |
2.26 |
| 2014-06-30 |
100.07 |
$42.16 |
2.37 |
| 2014-03-31 |
98.59 |
$41.54 |
2.37 |
| 2013-12-31 |
92.60 |
$41.14 |
2.25 |
| 2013-09-30 |
83.40 |
$40.49 |
2.06 |
| 2013-06-30 |
82.00 |
$39.35 |
2.08 |
| 2013-03-31 |
78.93 |
$38.66 |
2.04 |
| 2012-12-31 |
64.19 |
$37.76 |
1.70 |
| 2012-09-30 |
64.08 |
$36.66 |
1.75 |
| 2012-06-30 |
60.61 |
$35.51 |
1.71 |
| 2012-03-31 |
62.58 |
$34.60 |
1.81 |
| 2011-12-31 |
59.86 |
$33.93 |
1.76 |
| 2011-09-30 |
58.38 |
$33.42 |
1.75 |
| 2011-06-30 |
68.26 |
$31.93 |
2.14 |
| 2011-03-31 |
62.77 |
$30.88 |
2.03 |
| 2010-12-31 |
66.29 |
$29.83 |
2.22 |
| 2010-09-30 |
57.82 |
$29.61 |
1.95 |
| 2010-06-30 |
52.49 |
$29.83 |
1.76 |
| 2010-03-31 |
60.79 |
$29.55 |
2.06 |
| 2009-12-31 |
60.60 |
$29.10 |
2.08 |
| 2009-09-30 |
53.35 |
$31.82 |
1.68 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$67.707B |
$19.372B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
